We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Barkby Group Plc | LSE:BARK | London | Ordinary Share | GB00BL6TZZ70 | ORD �0.00860675675675676 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.60 | 3.20 | 4.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Hotels And Motels | 10.3M | -9.32M | -0.0651 | -1.26 | 11.75M |
TIDMBARK
RNS Number : 2826J
Barkby Group PLC
26 April 2022
26 April 2022
Barkby Group PLC
("Barkby" or the "Company")
Exchange of Contracts at Saffron Walden, Essex
Barkby Group PLC is pleased to announce it has unconditionally exchanged contracts to sell its site at Saffron Walden for GBP3.45m. Barkby currently has a book value of GBP1m for the site, the sale will result in a net profit of GBP2.3m for Barkby after disposal costs.
Completion has been agreed for 31(st) May 2022.
Charles Dickson, Executive Chairman of Barkby Group Plc, commented:
"I am delighted to have exchanged contracts for the sale of the site. Barkby has added significant value to the site through a series of successful planning applications which has resulted in a significant profit for shareholders."
Enquiries:
Barkby Group plc via Camarco Charles Dickson (Executive Chairman) Douglas Benzie (CFO) finnCap Ltd (Nomad and Broker) Carl Holmes/Simon Hicks (corporate finance) +44 (0) 20 7220 Tim Redfern/Richard Chambers (ECM) 0500 Camarco (Financial PR) +44 (0) 20 3757 Jennifer Renwick/Phoebe Pugh 4994
About The Barkby Group Plc:
Barkby Group PLC is a diversified group of high growth, high quality businesses run by an entrepreneurial and experienced management team. The existing wholly owned businesses units within Barkby include: Barkby Real Estate, Barkby Pub Co. and Barkby Investments (comprising of Workshop Coffee, Centurian Automotive, Cambridge Sleep Sciences and a minority stake in Verso Biosense).
Barkby's strategy is to accelerate and maximise opportunities within its existing businesses.
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the company's obligations under Article 17 of MAR.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
CNTBKPBBKBKBOQB
(END) Dow Jones Newswires
April 26, 2022 02:01 ET (06:01 GMT)
1 Year Barkby Chart |
1 Month Barkby Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions